Participated · Series B · Dec 2025

Castelion's flagship product is Blackbeard, described as a low-cost, mass-producible hypersonic strike missile engineered for industrial-rate output and continuous flight-test iteration. The company has progressed from early development to repeated flight testing, operational integration, and construction of a dedicated high-rate production capability, including the 1,000-acre Project Ranger manufacturing campus in New Mexico. Castelion has secured over $500 million in U.S. military contracts in the past 18 months and achieved program-of-record status for Blackbeard in under four years, with fielding targeted for 2027. Management and investors say the company is already producing hardware, mixing propellant in New Mexico, and shipping to the services. Castelion plans to use new capital to scale Blackbeard production, accelerate a longer-range precision strike weapon that leverages Blackbeard technologies, and develop lower-cost defensive systems. The company is headquartered in Torrance, California, with manufacturing operations in New Mexico, Texas, and California and offices in Washington, D.C. The Series C values the company at $13 billion following the $1 billion raise (comprised of $800 million equity and a $250 million revolving credit facility).

Participated · Series A · Dec 2023

Machinery Partner operates a B2B marketplace that enables manufacturers and dealers to sell heavy industrial equipment online, offering integrated procurement, financing, and service. The company is already selling in 35 U.S. states and plans to expand operations across the country and internationally. Its model targets construction, agriculture, and recycling companies and aims to deliver double-digit savings on critical equipment. Machinery Partner highlights equipment such as rock crushers, screeners, and shredders and positions itself to make high-cost, service-intensive machinery accessible to small and medium sized businesses. Headquartered in Boston, the company says the funding will help expand factory partnerships, increase equipment availability, and support broader market growth. The raise is presented as a step to disrupt the $580 billion global heavy equipment industry and support local infrastructure development. Machinery Partner offers an integrated model that combines procurement, financing and after-sale service to help small and medium-sized businesses acquire and operate heavy equipment. The company was founded in Ireland by CEO Ciaran Gillen and later relocated to Boston, MA. Its platform aims to democratize access to high-quality heavy machinery so customers can start or scale their businesses. In August 2021 Machinery Partner raised $4.5M in seed funding to support its growth. The company said it will use the funds to accelerate sales and to advance technology development. No operating metrics were disclosed in the article.

Participated · Series A · Mar 2022

ShopThing operates a live video shopping marketplace focused on luxury brands, delivered through its iOS app. Its network of shoppers and influencers livestream from stores, select products, and purchase on behalf of customers who browse time-limited deals in the app. ShopThing fulfills orders, completes checkout in-app, ships across Canada and the United States, and charges a 20% fee that covers the shopping service, purchase and shipment. Founded in 2018 by Maggie Adhami-Boynton, the company reports 500,000 users and more than 100 shoppers and influencers across North America. It has partnerships with brands including Stuart Weitzman, Nordstrom and Ted Baker and operates in cities such as Toronto, New York City, Miami and Los Angeles. The company plans to use new funding to add more shoppers, expand to 12–15 markets by year-end, grow its shopper team roughly fivefold, and launch a paid membership program in Q2.

Participated · Series A · Nov 2021

Yay Lunch provides a school meal solution that connects local restaurants to students, removing logistics burdens for school administrators and parents. Founded by Christina Liva Diiorio and Derek Mansfield and launched in 2018, the company began with a pilot in Spring 2018. It now serves over 100 schools across DC, Baltimore, Central Virginia, Atlanta and Philadelphia. The business emphasizes improving food quality and access where kids learn and play while supporting local communities and restaurants. Yay Lunch plans to use new funding to optimize its offering, build its team, expand its geographic footprint and deepen penetration in its current markets. To date the company has raised $15.5M in total financing.

Participated · Series C · Nov 2019

AiCure develops AI-driven software and analytics to enhance patient engagement, digital biomarkers, and sponsor insights in clinical trials. The company’s platform is positioned to improve monitoring and outcomes for life‑science sponsors running trials. In 2023 AiCure was granted seven new U.S. patents, bringing its total U.S. patent count to 86, with additional patents issued globally. On January 25, 2024, AiCure completed a $12M loan refinancing and raised an additional $4M+ from existing investors. The company said the proceeds will be used to invest in research and development, expand operations, and enhance its products and services. AiCure also added two senior hires: Sondra Pepe as SVP of Product Management and Josh Wilson as SVP of Operations. AiCure is an AI-driven healthcare platform that uses artificial intelligence to see, hear and understand how people respond to treatment in clinical trials and patient care. Its technologies are clinically proven to measure and modify patient behavior, helping keep patients engaged and optimized for treatment and to evaluate treatment effectiveness. The company holds more than 100 registered patents and works with global clients in more than 25 countries. AiCure was founded in 2010 and is led by CEO Adam Hanina. The company is based in New York City. It raised $24.5M in a Series C and intends to use the funds to accelerate its business activities. AiCure offers a mobile software-as-a-service platform that uses machine learning, computer vision, and big data to visually confirm patients’ medication ingestion. The technology has been validated against drug levels in blood samples and across patient populations including elderly stroke patients and participants in schizophrenia and HIV prevention trials. AiCure partners with pharmaceutical companies and government institutions to monitor medication adherence and optimize treatment models. The company is led by CEO Adam Hanina and operates from New York City. Financially, AiCure completed a Series A financing to support its operations and partnerships. The platform targets clinical-trial and treatment-adherence use cases through its AI-driven verification and monitoring capabilities.